Showing results (1001-1010 of 1,024) with videos related to

Sort By:
Pageof 103
Frontiers in Immunology|September 20, 2021
Immune Recovery Following Autologous Hematopoietic Stem Cell Transplantation in HIV-Related Lymphoma Patients on the BMT CTN 0803/AMC 071 TrialPolina Shindiapina, Maciej Pietrzak, Michal Seweryn, et al.
Journal of Child Neurology|March 21, 2012
Consensus statement on standard of care for congenital myopathiesChing H Wang, James J Dowling, Kathryn North, et al.
Leukemia|February 26, 2020
Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trialsMaria Gavriatopoulou, Ajai Chari, Christine Chen, et al.
Ambio|December 19, 2024
Can triad forestry reconcile Europe's biodiversity and forestry strategies? A critical evaluation of forest zoningThomas A Nagel, Mariano Rodríguez-Recio, Tuomas Aakala, et al.
Journal of Food Protection|April 17, 2025
Investigation of Two Outbreaks of Hepatitis A Virus Infections Linked to Fresh and Frozen Strawberries Imported from Mexico - 2022-2023Monica McClure, Margaret Kirchner, Tiffany Greenlee, et al.
American Journal of Respiratory and Critical Care Medicine|April 16, 2024
Autoimmunity Against Surfactant Protein B Is Associated with Pneumonitis During Checkpoint BlockadeNina Wyss, Fiamma Berner, Vincent Walter, et al.
The Journal of Allergy and Clinical Immunology|February 8, 2017
International consensus guidelines for the diagnosis and management of food protein-induced enterocolitis syndrome: Executive summary-Workgroup Report of the Adverse Reactions to Foods Committee, American Academy of Allergy, Asthma & ImmunologyAnna Nowak-Węgrzyn, Mirna Chehade, Marion E Groetch, et al.
The New England Journal of Medicine|May 11, 2012
Lenalidomide after stem-cell transplantation for multiple myelomaPhilip L McCarthy, Kouros Owzar, Craig C Hofmeister, et al.
Nature Communications|January 23, 2026
European forest carbon and biodiversity policies have a limited win-win potentialLorenzo Balducci, Elena Haeler, Yoan Paillet, et al.
The Lancet. Haematology|August 23, 2017
Updated analysis of CALGB (Alliance) 100104 assessing lenalidomide versus placebo maintenance after single autologous stem-cell transplantation for multiple myeloma: a randomised, double-blind, phase 3 trialSarah A Holstein, Sin-Ho Jung, Paul G Richardson, et al.
Pageof 103